CXCL1 and skin basal cell carcinoma: Wang et al.51 demonstrated that visfatin-induced M2 differentiation in monocytes via CXCL1/ERK phosphorylation enhance BCC viability, migration, and EMT in vitro and in orthotopic mouse models.